Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia.
COVID-19
Colombia
SARS
SARS-CoV-2
coronavirus
coronavirus disease
genome sequencing
phylogenomics
respiratory infections
severe acute respiratory syndrome coronavirus 2
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
entrez:
21
11
2020
pubmed:
22
11
2020
medline:
15
12
2020
Statut:
ppublish
Résumé
Coronavirus disease (COVID-19) in Colombia was first diagnosed in a traveler arriving from Italy on February 26, 2020. However, limited data are available on the origins and number of introductions of COVID-19 into the country. We sequenced the causative agent of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from 43 clinical samples we collected, along with another 79 genome sequences available from Colombia. We investigated the emergence and importation routes for SARS-CoV-2 into Colombia by using epidemiologic, historical air travel, and phylogenetic observations. Our study provides evidence of multiple introductions, mostly from Europe, and documents >12 lineages. Phylogenetic findings validate the lineage diversity, support multiple importation events, and demonstrate the evolutionary relationship of epidemiologically linked transmission chains. Our results reconstruct the early evolutionary history of SARS-CoV-2 in Colombia and highlight the advantages of genome sequencing to complement COVID-19 outbreak investigations.
Identifiants
pubmed: 33219646
doi: 10.3201/eid2612.202969
pmc: PMC7706936
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2854-2862Subventions
Organisme : Medical Research Council
ID : MC_PC_19012
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R024855/1
Pays : United Kingdom
Références
J Mol Evol. 1985;22(2):160-74
pubmed: 3934395
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
BMC Med. 2020 May 7;18(1):124
pubmed: 32375776
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
J Med Virol. 2020 Sep;92(9):1562-1566
pubmed: 32222995
Bioinformatics. 2018 Sep 1;34(17):i884-i890
pubmed: 30423086
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Nat Microbiol. 2019 Jan;4(1):10-19
pubmed: 30546099
Science. 2020 Sep 4;369(6508):1255-1260
pubmed: 32703910
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Int J Equity Health. 2020 Jun 8;19(1):91
pubmed: 32513261
Science. 2020 May 1;368(6490):493-497
pubmed: 32213647
Lancet Public Health. 2020 May;5(5):e261-e270
pubmed: 32220655
Virus Evol. 2020 Apr 10;6(1):veaa027
pubmed: 32296544
N Engl J Med. 2020 Jun 11;382(24):2302-2315
pubmed: 32289214
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
J Travel Med. 2020 May 18;27(3):
pubmed: 32211799
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
Lancet Digit Health. 2020 Apr;2(4):e201-e208
pubmed: 32309796
Syst Biol. 2016 Jan;65(1):82-97
pubmed: 26424727
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Am J Trop Med Hyg. 2020 Jun;102(6):1210-1213
pubmed: 32342849
Cell. 2020 May 28;181(5):997-1003.e9
pubmed: 32359424
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638
Science. 2020 Apr 24;368(6489):395-400
pubmed: 32144116
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508